Drugs / DA-2811-R
last change Aug 2021 re-read 2 minutes ago

DA-2811-R

Investigated by
Dong-A ST Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04938752 Jul → Aug 2021 Dong-A ST Co., Ltd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DA-2811-R ClinicalTrials.gov intervention name — accepted as the source's own label NCT04938752
Route Oral “single oral dose” NCT04938752